Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,269-2,280 of 4,306
Drug study icon
CompletedNCT01149655

Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Downy
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, India, Malaysia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00101634

Long Acting Anti-Psychotic for schizophrenia

This study is completed. It is testing Long Acting Anti-Psychotic for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT02970292

Pimavanserin for schizophrenia

This study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00487942

Armodafinil for Schizophrenia

This study is completed in the United States. It is testing armodafinil for Schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Cephalon
Condition
Schizophrenia
Drug study icon
TerminatedNCT00439634

AVE1625 for schizophrenia

This study was terminated in the United States and in Canada. It is testing AVE1625 for schizophrenia.

Multiple locations, including Bridgewater
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Canada
Sponsor
Sanofi
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00639483

Celecoxib for schizophrenia

This study is completed in Argentina, in Brazil, in Germany, .... It is testing celecoxib for schizophrenia.

Multiple locations, including La Plata
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 50 Years
Countries
Argentina, Brazil, Germany, ...
Sponsor
Pfizer
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.